SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001062993-17-002869
Filing Date
2017-06-12
Accepted
2017-06-12 15:04:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sch13ga_merus.htm SC 13G/A 19071
  Complete submission text file 0001062993-17-002869.txt   21150
Mailing Address 1 ADELAIDE STREET EAST 29TH FLOOR TORONTO A6 M5V 2C9
Business Address 1 ADELAIDE STREET EAST 29TH FLOOR TORONTO A6 M5V 2C9 4168636990
1832 Asset Management L.P. (Filed by) CIK: 0000944388 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6
Type: SC 13G/A

Mailing Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1
Business Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1 416 593-3701
Merus Labs International Inc. (Subject) CIK: 0001031516 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-81986 | Film No.: 17906069
SIC: 2834 Pharmaceutical Preparations